| NCT03397004 |
Doxycycline for Hereditary Hemorrhagic Telangiectasia |
https://ClinicalTrials.gov/show/NCT03397004 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-12-31 |
| NCT03321916 |
MacTel Laser Study |
https://ClinicalTrials.gov/show/NCT03321916 |
Recruiting |
The Lowy Medical Research Institute Limited |
2020-12-31 |
| NCT03319849 |
A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 |
https://ClinicalTrials.gov/show/NCT03319849 |
Recruiting |
Neurotech Pharmaceuticals |
2022-03-31 |
| NCT03316300 |
A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 |
https://ClinicalTrials.gov/show/NCT03316300 |
Recruiting |
Neurotech Pharmaceuticals |
2022-03-31 |
| NCT03071965 |
Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) |
https://ClinicalTrials.gov/show/NCT03071965 |
Enrolling by invitation |
Neurotech Pharmaceuticals |
2021-04-15 |
| NCT02977637 |
MRA With Feraheme in HHT |
https://ClinicalTrials.gov/show/NCT02977637 |
Completed |
University of California, Los Angeles |
2018-11-30 |
| NCT02770807 |
EDS in Ataxia Telangiectasia Patients |
https://ClinicalTrials.gov/show/NCT02770807 |
Recruiting |
Erydel |
2020-11-30 |
| NCT02761174 |
Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias |
https://ClinicalTrials.gov/show/NCT02761174 |
Completed |
Bispebjerg Hospital |
2016-07-11 |
| NCT02754479 |
A Clinical Evaluation of the Treatment of Spider Veins on the Ankles |
https://ClinicalTrials.gov/show/NCT02754479 |
Completed |
Cutera Inc. |
2017-03-31 |
| NCT02733679 |
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone |
https://ClinicalTrials.gov/show/NCT02733679 |
Completed |
NHS Tayside |
2017-08-30 |
| NCT02657252 |
Polidocanol Versus Glucose Treatment of Telangiectasia Trial |
https://ClinicalTrials.gov/show/NCT02657252 |
Completed |
UPECLIN HC FM Botucatu Unesp |
2016-09-30 |
| NCT02484716 |
Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO) |
https://ClinicalTrials.gov/show/NCT02484716 |
Completed |
Hospices Civils de Lyon |
2017-11-30 |
| NCT02464644 |
Frequency of Common Medical Conditions in People With and Without HHT |
https://ClinicalTrials.gov/show/NCT02464644 |
Completed |
Imperial College London |
2015-05-31 |
| NCT02389959 |
Intranasal Bevacizumab for HHT-Related Epistaxis |
https://ClinicalTrials.gov/show/NCT02389959 |
Recruiting |
Stanford University |
2019-09-30 |
| NCT02345200 |
Body Composition and Hormonal Status in Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT02345200 |
Completed |
Johann Wolfgang Goethe University Hospital |
2014-04-30 |
| NCT02345135 |
Susceptibility to Infections in Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT02345135 |
Completed |
Johann Wolfgang Goethe University Hospital |
2016-01-31 |
| NCT02287558 |
Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study |
https://ClinicalTrials.gov/show/NCT02287558 |
Recruiting |
The Cleveland Clinic |
2019-06-30 |
| NCT02104271 |
Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial. |
https://ClinicalTrials.gov/show/NCT02104271 |
Completed |
Barretos Cancer Hospital |
2014-12-31 |
| NCT01314274 |
Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) |
https://ClinicalTrials.gov/show/NCT01314274 |
Completed |
Medical University of Vienna |
2013-06-30 |
| NCT03152019 |
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT) |
https://ClinicalTrials.gov/show/NCT03152019 |
Completed |
Hospices Civils de Lyon |
2018-11-08 |
| NCT04113187 |
Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients |
https://ClinicalTrials.gov/show/NCT04113187 |
Recruiting |
University Hospital, Bordeaux |
2022-06-30 |
| NCT01975103 |
Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases |
https://ClinicalTrials.gov/show/NCT01975103 |
Recruiting |
Federal University of Rio Grande do Sul |
2020-04-30 |
| NCT01949324 |
A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel |
https://ClinicalTrials.gov/show/NCT01949324 |
Completed |
Neurotech Pharmaceuticals |
2017-04-14 |
| NCT01752049 |
Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept |
https://ClinicalTrials.gov/show/NCT01752049 |
Completed |
St. Michael’s Hospital, Toronto |
2019-08-30 |
| NCT01507480 |
The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia |
https://ClinicalTrials.gov/show/NCT01507480 |
Completed |
Hospices Civils de Lyon |
2012-12-31 |
| NCT01491620 |
Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte |
https://ClinicalTrials.gov/show/NCT01491620 |
Completed |
Cutera Inc. |
2013-05-31 |
| NCT01485224 |
Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia |
https://ClinicalTrials.gov/show/NCT01485224 |
Completed |
IRCCS Policlinico S. Matteo |
2014-10-31 |
| NCT01408732 |
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia |
https://ClinicalTrials.gov/show/NCT01408732 |
Completed |
University of Minnesota |
2014-09-30 |
| NCT01408030 |
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) |
https://ClinicalTrials.gov/show/NCT01408030 |
Completed |
Augusta University |
2014-09-30 |
| NCT01402531 |
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) |
https://ClinicalTrials.gov/show/NCT01402531 |
Completed |
University of California, San Diego |
2013-07-27 |
| NCT01397695 |
Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) |
https://ClinicalTrials.gov/show/NCT01397695 |
Completed |
University of California, San Diego |
2014-01-31 |
| NCT01362192 |
Treatment of Lower Extremity Spider Veins With Excel V |
https://ClinicalTrials.gov/show/NCT01362192 |
Completed |
Cutera Inc. |
2011-11-30 |
| NCT01327911 |
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel) |
https://ClinicalTrials.gov/show/NCT01327911 |
Completed |
Neurotech Pharmaceuticals |
2016-09-30 |
| NCT04336163 |
Skin Imaging to Inform Laser Treatments |
https://ClinicalTrials.gov/show/NCT04336163 |
Recruiting |
University of California, Irvine |
2020-12-31 |
| NCT04274842 |
D-OCT of Facial Telangiectasia Treated With IPL |
https://ClinicalTrials.gov/show/NCT04274842 |
Completed |
Zealand University Hospital |
2018-10-01 |
| NCT04148950 |
Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous Disease |
https://ClinicalTrials.gov/show/NCT04148950 |
Completed |
Istanbul University |
2015-05-31 |
| NCT04139018 |
Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia |
https://ClinicalTrials.gov/show/NCT04139018 |
Recruiting |
Washington University School of Medicine |
2020-10-20 |
| NCT04132323 |
Low Concentrate Detergents Versus Hypertonic Glucose for the Treatment of Telangiectasia |
https://ClinicalTrials.gov/show/NCT04132323 |
Recruiting |
Derzhavin Tambov State University |
2020-07-15 |
| NCT04108052 |
Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient |
https://ClinicalTrials.gov/show/NCT04108052 |
Recruiting |
Hospices Civils de Lyon |
2020-11-30 |
| NCT04004728 |
Laser Treatment Of Leg Telangiectasias |
https://ClinicalTrials.gov/show/NCT04004728 |
Completed |
University of Sao Paulo |
2011-08-31 |
| NCT03981562 |
Vitamin D and Hereditary Haemorrhagic Telangiectasia |
https://ClinicalTrials.gov/show/NCT03981562 |
Recruiting |
St. Paul’s Hospital, Canada |
2020-07-01 |
| NCT03962114 |
Effects of Vitamin B3 in Patients With Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT03962114 |
Enrolling by invitation |
Radboud University |
2019-12-01 |
| NCT03940690 |
Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease |
https://ClinicalTrials.gov/show/NCT03940690 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2022-11-30 |
| NCT03910244 |
Pomalidomide for the Treatment of Bleeding in HHT |
https://ClinicalTrials.gov/show/NCT03910244 |
Recruiting |
The Cleveland Clinic |
2022-03-31 |
| NCT03759678 |
N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) |
https://ClinicalTrials.gov/show/NCT03759678 |
Recruiting |
IntraBio Inc |
2020-07-01 |
| NCT03669393 |
A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1) |
https://ClinicalTrials.gov/show/NCT03669393 |
Recruiting |
Oxurion |
2019-12-31 |
| NCT03646955 |
Partial Breast Versus no Irradiation for Women With Early Breast Cancer |
https://ClinicalTrials.gov/show/NCT03646955 |
Recruiting |
Danish Breast Cancer Cooperative Group |
2033-09-01 |
| NCT03563053 |
Open-label, Long-term, Extension Treatment Using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients With Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study |
https://ClinicalTrials.gov/show/NCT03563053 |
Recruiting |
Erydel |
2020-08-31 |
| NCT03472859 |
Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser |
https://ClinicalTrials.gov/show/NCT03472859 |
Completed |
Tampere University Hospital |
2018-06-09 |
| NCT01205035 |
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia |
https://ClinicalTrials.gov/show/NCT01205035 |
Completed |
Eye Center of Northern Colorado, P.C. |
2012-10-31 |
| NCT01031992 |
Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) |
https://ClinicalTrials.gov/show/NCT01031992 |
Completed |
University Hospital, Saarland |
2002-08-31 |
| NCT00950196 |
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia |
https://ClinicalTrials.gov/show/NCT00950196 |
Completed |
Sheba Medical Center |
2009-11-30 |
| NCT00843440 |
Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study |
https://ClinicalTrials.gov/show/NCT00843440 |
Completed |
Hospices Civils de Lyon |
2009-03-31 |
| NCT02638012 |
Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) |
https://ClinicalTrials.gov/show/NCT02638012 |
Completed |
St. Michael’s Hospital, Toronto |
2019-10-31 |
| NCT03845049 |
Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1 |
https://ClinicalTrials.gov/show/NCT03845049 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2022-01-31 |
| NCT03227263 |
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). |
https://ClinicalTrials.gov/show/NCT03227263 |
Completed |
Hospices Civils de Lyon |
2020-05-15 |
| NCT02286804 |
Ultherapy for the Treatment of Spider Veins on the Legs |
https://ClinicalTrials.gov/show/NCT02286804 |
Completed |
Merz North America, Inc. |
2015-04-30 |
| NCT00725244 |
Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias |
https://ClinicalTrials.gov/show/NCT00725244 |
Completed |
Federal University of São Paulo |
2007-11-30 |
| NCT00685854 |
Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth |
https://ClinicalTrials.gov/show/NCT00685854 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-03-24 |
| NCT00685503 |
Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth |
https://ClinicalTrials.gov/show/NCT00685503 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-04-12 |
| NCT00656409 |
Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) |
https://ClinicalTrials.gov/show/NCT00656409 |
Completed |
Institute of Child Health |
NA |
| NCT00640003 |
Baclofen Treatment of Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT00640003 |
Completed |
Johns Hopkins University |
2011-02-28 |
| NCT00504400 |
Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial) |
https://ClinicalTrials.gov/show/NCT00504400 |
Completed |
University Hospital, Bonn |
2009-06-30 |
| NCT00470977 |
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy |
https://ClinicalTrials.gov/show/NCT00470977 |
Completed |
Manhattan Eye, Ear & Throat Hospital |
2010-12-31 |
| NCT00457145 |
Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation |
https://ClinicalTrials.gov/show/NCT00457145 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00457067 |
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation |
https://ClinicalTrials.gov/show/NCT00457067 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00451763 |
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia |
https://ClinicalTrials.gov/show/NCT00451763 |
Completed |
University of Sao Paulo |
2006-12-31 |
| NCT00389935 |
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding |
https://ClinicalTrials.gov/show/NCT00389935 |
Completed |
Northport Veterans Affairs Medical Center |
2011-06-30 |
| NCT00378196 |
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial |
https://ClinicalTrials.gov/show/NCT00378196 |
Completed |
Johns Hopkins University |
2007-09-30 |
| NCT00375622 |
Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial |
https://ClinicalTrials.gov/show/NCT00375622 |
Completed |
Rabin Medical Center |
NA |
| NCT00355108 |
ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome |
https://ClinicalTrials.gov/show/NCT00355108 |
Completed |
Hospices Civils de Lyon |
2010-05-31 |
| NCT00211328 |
Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.). |
https://ClinicalTrials.gov/show/NCT00211328 |
Completed |
Manhattan Eye, Ear & Throat Hospital |
NA |
| NCT00187057 |
Study for Treatment of Cancer in Children With Ataxia-telangiectasia |
https://ClinicalTrials.gov/show/NCT00187057 |
Completed |
St. Jude Children’s Research Hospital |
2006-08-31 |
| NCT00004654 |
Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia |
https://ClinicalTrials.gov/show/NCT00004654 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004327 |
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia |
https://ClinicalTrials.gov/show/NCT00004327 |
Completed |
Office of Rare Diseases (ORD) |
NA |